Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Computing & Software
5 pending office actions • 2 art units • 2 examiners • 0 of 5 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Glatt GmbH is managing 5 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are handled by 2 distinct examiners across 2 distinct art units. This indicates a degree of concentration, as multiple matters are being reviewed by the same group of officials. The 2 distinct art units suggest the portfolio is focused on specific technical niches within the broader Biotechnology & Pharmaceuticals field, requiring specialized expertise in those areas.
The busiest examiner, ALAM, AYAAN A, is responsible for 4 busiest examiner pending actions. This means that 4 out of the 5 pending office actions are assigned to this individual. Consequently, the outcome of the majority of the portfolio's current prosecution depends on the specific examination style of ALAM, AYAAN A within the 2 distinct art units involved. Practitioners should prioritize understanding the preferences of this examiner to manage the 5 pending office actions effectively. The concentration of 4 busiest examiner pending actions under this official simplifies the coordination of responses but increases the impact of a single examiner's perspective.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (20%) |
| §103 only | 4 (80%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ALAM, AYAAN A | 4 | 38.4% | +35.6% |
| CHANNAVAJJALA, SRIRAMA T | 1 | 74.4% | +32.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18969479 | Archiving System and Method for Archiving Electronic Data | CHANNAVAJJALA, SRIRAMA T | 69d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16513068 | EXTENDED RELEASE FORMULATIONS OF CANNABINOIDS | ALAM, AYAAN A | 91d overdue |
| 16513238 | MULTIPARTICULATE FORMULATIONS OF CANNABINOIDS | ALAM, AYAAN A | 45d overdue |
| 18969479 | Archiving System and Method for Archiving Electronic Data | CHANNAVAJJALA, SRIRAMA T | 69d |
| 17081189 | MULTIPARTICULATE FORMULATIONS OF CANNABINOIDS | ALAM, AYAAN A | — |
| 17081170 | MULTIPARTICULATE FORMULATIONS OF CANNABINOIDS | ALAM, AYAAN A | — |
| Art Unit | Apps |
|---|---|
| 1611 | 4 |
| 2154 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18969479 | Archiving System and Method for Archiving Electronic Data | CHANNAVAJJALA, SRIRAMA T | 2154 | §101§103 | Final Rejection | 69d | Pending | Dec 05, 2024 |
| 17081189 | MULTIPARTICULATE FORMULATIONS OF CANNABINOIDS | ALAM, AYAAN A | 1611 | §103 | Final Rejection | — | Pending | Oct 27, 2020 |
| 17081170 | MULTIPARTICULATE FORMULATIONS OF CANNABINOIDS | ALAM, AYAAN A | 1611 | §103 | Final Rejection | — | Pending | Oct 27, 2020 |
| 16513238 | MULTIPARTICULATE FORMULATIONS OF CANNABINOIDS | ALAM, AYAAN A | 1611 | §103 | Final Rejection | 45d overdue | Pending | Jul 16, 2019 |
| 16513068 | EXTENDED RELEASE FORMULATIONS OF CANNABINOIDS | ALAM, AYAAN A | 1611 | §103 | Non-Final OA | 91d overdue | Pending | Jul 16, 2019 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial